FDI of the Month

FDI of the month May 2022: Horizon Therapeutics to create 100 new jobs in Dublin and Waterford

By Business & Finance
01 June 2022

Horizon Therapeutics, which focuses on the discovery, development and commercialisation of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases, opened its new global headquarters in Dublin and announced the creation of 100 jobs in both Dublin and Waterford over the next 18 months.

Horizon Therapeutics’s new 62,000 square foot facility is located at 70 St Stephen’s Green in Dublin city centre.

The company’s global headquarters have been in Dublin since 2014 and they have around 200 employees across Ireland in many different sectors including finance, legal, technical operations and research and development.

Last year Horizon bought a 44,000 square foot manufacturing facility in Waterford to support the growth of its on-market rare disease medicines and pipeline biologics.

Horizon chairman, Timothy P Walbert expressed how great of a location Ireland has been to the company.

As a company we benefit enormously from the rich pool of talented and enthusiastic employees here. 

“Ireland is a key part of our global strategy and we will continue to invest significantly here to enhance our business and to demonstrate our support for the wider community”, he continued.

Taoiseach Micheál Martin welcomed the company’s commitment to creating a further 100 jobs in Waterford and Dublin over the next 18 months.

“The company’s decision to add a manufacturing facility in Waterford last year further underlines the leading role Ireland plays in the company’s operations. Horizon’s drive and commitment to innovation and its highly skilled and talented workforce here will continue to bring the company considerable further success in the years ahead”, he said.

Martin Shanahan, CEO of IDA Ireland said that Horizon’s investments and job creation in both its Dublin HQ and manufacturing facility in Waterford is more than welcome and will help with Ireland’s growing biopharma industry.

Horizon Therapeutics was founded in 2005. It currently employs 2,000 people worldwide and includes nine offices across the globe.